Evidence map›Paper›PMID 27438820›Full record

ArticleMolecules (Basel, Switzerland)2016

Layered Double Hydroxide as a Vehicle to Increase Toxicity of Gallate Ions against Adenocarcinoma Cells.

Jenny Arratia-Quijada, Selma Rivas-Fuentes, Karina J Parra Saavedra, Adriana M Macías Lamas, Gregorio Guadalupe Carbajal Arízaga

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jenny Arratia-QuijadaDepartamento de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Avenida Nuevo Periférico 555, 48525 Tonalá, Jalisco, Mexico. jenny.arratia@cutonala.udg.mx.
Selma Rivas-FuentesDepartamento de Bioquímica, Instituto Nacional de Enfermedades Respiratorias, Calzada de Tlalpan 4502, 14080 Mexico City, Mexico. selma.rivas@iner.gob.mx.
Karina J Parra SaavedraDepartamento de Química, Universidad de Guadalajara, Marcelino García Barragán 1421, 44430 Guadalajara, Jalisco, Mexico. karina_ps21@hotmail.com.
Adriana M Macías LamasDepartamento de Farmacobiología, Universidad de Guadalajara, Marcelino García Barragán 1421, 44430 Guadalajara, Jalisco, Mexico. amaciaslamas@yahoo.com.
Gregorio Guadalupe Carbajal ArízagaDepartamento de Química, Universidad de Guadalajara, Marcelino García Barragán 1421, 44430 Guadalajara, Jalisco, Mexico. gregoriocarbajal@yahoo.com.mx.
Universidad de Guadalajara · MXInstituto Nacional de Enfermedades Respiratorias · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antineoplasic activity of gallic acid has been reported. This compound induces apoptosis and inhibits the growth of several neoplasic cells. However, this molecule is easily oxidized and degraded in the body. The aim of this work was to intercalate gallate ions into layered double hydroxide (LDH) nanoparticles under controlled conditions to reduce oxidation of gallate and to evaluate its toxicity against the A549 adenocarcinoma cell line. An isopropanol medium under nitrogen atmosphere was adequate to intercalate gallate ions with a lesser oxidation degree as detected by electron spin resonance spectroscopy. Concentrations of the hybrid LDH-gallate nanoparticles between 0.39 and 25 µg/mL reduced the cell viability to 67%, while the value reached with the pure gallic acid and LDH was 90% and 78%, respectively, thus proving that the combination of gallate ions with the inorganic nanoparticles increases the toxicity potential within this dose range.

Indexed as

AdenocarcinomaAntineoplastic Agents, PhytogenicCell Line, TumorCell SurvivalDrug CarriersElectron Spin Resonance SpectroscopyGallic AcidHumansHydroxidesIonsNanoparticlesSpectroscopy, Fourier Transform InfraredThermogravimetryX-Ray DiffractionAntineoplastic Agents, PhytogenicDrug CarriersGallic AcidHydroxidesIonsgallicnanocarriernanomedicinenanoparticle

Identifiers

PMID27438820
PMCPMC6273741
OpenAlexW2491352592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.